Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke de Boer

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Ophthalmology|March 28, 2006
A randomized, masked, cross-over trial of lisinopril for inflammatory macular edemaBram van Kooij, Rob Fijnheer, Joke de Boer, et al.
Ocular Immunology and Inflammation|November 15, 2023
Uveitis Associated with Juvenile Idiopathic ArthritisCharlotte van Meerwijk, Jonas Kuiper, Joeri van Straalen, et al.
American Journal of Ophthalmology|February 17, 2019
Clinical Manifestations, Prognosis, and Vaccination Status of Patients With Rubella Virus-Associated UveitisFahriye Groen-Hakan, Suzanne van de Laar, Annemiek A van der Eijk-Baltissen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case seriesRoselie Achten, Coco Dekkers, Daphne Bakker, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
Allergy|March 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysisRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 23, 2022
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patientsRoselie Achten, Judith Thijs, Chantal van Luijk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2020
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitisRoselie Achten, Daphne Bakker, Lieneke Ariens, et al.
Ocular Immunology and Inflammation|February 28, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular ProfileRoselie Achten, Chantal van Luijk, Judith Thijs, et al.
Arthritis Care & Research|March 23, 2012
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArnd Heiligenhaus, Ivan Foeldvari, Clive Edelsten, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Ophthalmology|March 28, 2006
A randomized, masked, cross-over trial of lisinopril for inflammatory macular edemaBram van Kooij, Rob Fijnheer, Joke de Boer, et al.
Ocular Immunology and Inflammation|November 15, 2023
Uveitis Associated with Juvenile Idiopathic ArthritisCharlotte van Meerwijk, Jonas Kuiper, Joeri van Straalen, et al.
American Journal of Ophthalmology|February 17, 2019
Clinical Manifestations, Prognosis, and Vaccination Status of Patients With Rubella Virus-Associated UveitisFahriye Groen-Hakan, Suzanne van de Laar, Annemiek A van der Eijk-Baltissen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 16, 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case seriesRoselie Achten, Coco Dekkers, Daphne Bakker, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
Allergy|March 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysisRoselie Achten, Judith Thijs, Marlot van der Wal, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 23, 2022
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patientsRoselie Achten, Judith Thijs, Chantal van Luijk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2020
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitisRoselie Achten, Daphne Bakker, Lieneke Ariens, et al.
Ocular Immunology and Inflammation|February 28, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular ProfileRoselie Achten, Chantal van Luijk, Judith Thijs, et al.
Arthritis Care & Research|March 23, 2012
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArnd Heiligenhaus, Ivan Foeldvari, Clive Edelsten, et al.
Pageof 4